Yale Technologies
Yale Ventures oversees Yale's technology transfer office, protecting and licensing the intellectual property developed at Yale, and helping to bring breakthroughs to market as products and services that can make a difference in the world.
Yale Technologies Available for Licensing
Yale Principal Investigator Pitches and Presentations
Search (Pitches)
Search (Pitches)
-
Harnessing p53beta as a medical treatment of skin cancer
Christine Ko, MD -
First in Class Ferroptosis Inhibitors: For Preventative Treatment of Delayed Graft Function in Kidney Transplantation and other Ferroptosis-related indications
Dianqing (Dan) Wu, PhD -
-
curIOS Therapeutics: mRNA therapies targeting the driver antigens in virus-associated cancers
Jeffrey Ishizuka, MD, DPhil -
Innovative approach to treat ALS using a novel small molecule target
Janghoo Lim, PhD -
Small molecule and enzymatic approaches to revert aberrant phase transitions in neurological disorders
Christian Schlieker, PhD -
Advancing a non-hallucinogenic psychedelic drug combination
Alfred Kaye, MD, PhD -
D2B3 - Drug Delivery across the Blood Brain Barrier
Anne Eichmann, PhD -
The Dermcyt platform: bringing modern immunology to diagnosis and personalized treatment selection of inflammatory skin diseases
William Damsky, MD, PhD -
Targeted Vimentin Inhibitor to Prevent Lung Cancer Progression and Metastasis
Christopher G Bunick, MD/PhD